Rezolute
D

RZLT

3.81500
USD
-0.05
(-1.17%)
مغلق
حجم التداول
0
الربح لكل سهم
-1
العائد الربحي
-
P/E
-5
حجم السوق
368,995,700

العنوان: Rezolute

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Rezolute Inc is a late-stage rare disease company focused on developing therapies that treat refractory and debilitating hypoglycemia associated with various forms of hyperinsulinism. Its main clinical asset, Ersodetug, is a potential treatment for refractory hypoglycemia caused by multiple forms of hyperinsulinism. The company has a single reportable segment, which includes all of its activities as a clinical-stage biopharmaceutical company.